Searching map area
Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor
? TBD
scientific article published on 17 December 2012
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Georgina Long
Grant McArthur
Richard F. Kefford
Antoni Ribas (professor)
Patrick Hwu
Jeffrey A Sosman
Michael Millward
Daniele Ouellet
Kiran D Patel
Jeffrey R Infante
Anna C Pavlick
Subject
Patient
trametinib dimethyl sulfoxide
Trametinib
References
Wikidata